Find information on thousands of medical conditions and prescription drugs.

Cotinine

Cotinine is a break-down product of nicotine from cigarette smoke. Cotinine typically remains in the blood between 48 and 96 hours. The level of cotinine in the blood is proportionate to the amount of exposure to tobacco smoke, so it is a valuable indicator of tobacco smoke exposure, including secondary smoke. Women who smoke menthol cigarettes retain cotinine in the blood for a longer period. Race may also play a role, as blacks routinely register higher blood cotinine levels than whites. more...

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Several variable factors, such as menthol cigarette preference and puff size, suggest that the explanation for this difference may be more complex than gender or race.

Drug tests can detect cotinine in the blood, urine, or saliva.

The word 'cotinine' is an anagram of 'nicotine'.

Chemical Name: (S)-1-methyl-5-(3-pyridinyl)-2-Pyrrolidinone

Synonymes: Cotinine; (-)-Cotinine; 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone;

Chemical Formula: C10H12N2O

Molar mass: 176.22 g/mol

There is some research being done on the memory and brain-function improving effects of cotinine. Cotinine (as well as nicotine) appears to improve memory function, and prevent cell death. For this reason it has been studied for effectiveness in treating Alzheimer's disease.

Read more at Wikipedia.org


[List your site here Free!]


Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys - Statistical Data Included
From British Medical Journal, 8/5/00 by Martin J Jarvis

Abstract

Objective To determine whether children's exposure to passive smoking has changed since the late 1980s.

Design Cross sectional surveys of nationally representative samples of secondary school children carried out between 1988 and 1998 by Office for National Statistics.

Setting England.

Subjects Secondary school children aged 11-15.

Main outcome measures Salivary cotinine concentrations in non-smoking children.

Results Cotinine concentrations in all non-smoking children almost halved between 1988 and 1998, from a geometric mean of 0.96 (95% confidence interval 0.83 to 1.11) ng/ml in 1988 to 0.52 (0.43 to 0.62) ng/ml in 1998. This reduction was largely due to reductions in exposure in children from non-smoking households and to decreases in the percentage of parents who smoked. Children living with mothers or fathers who smoked experienced little reduction in exposure.

Conclusions Exposure to passive smoking among children in England has approximately halved since the late 1980s. This reduction is partly explained by the fall in the percentage of both mothers and fathers who smoke and is also likely to reflect reductions of smoking in public places. However, there is only limited evidence that children from smoking households have experienced a reduction in exposure through parents' avoidance of smoking in their presence.

Introduction

The past decade has seen increasing restrictions on smoking in public places. Many workplaces in Britain have introduced smoking policies, and smoking has been banned on buses and the underground and in banks cinemas, post offices, and shops. Smoking in the home is less easily regulated. Much of the public health burden from passive smoking falls on children in the home, with clear evidence of causal effects for several diseases.[1] There are reports from the United States and elsewhere of adult smokers, while not quitting smoking, implementing smoking bans in their homes.[2-5] The impact of this on children's measured exposure has not been established.

We here report cotinine concentrations in children measured during school based surveys carried out since 1988. We consider concentrations in children with non-smoking parents as an indicator of influences from broad trends in society, and we examine whether there is evidence for a decline in exposure among children with smoking parents.

Subjects and methods

Data were drawn from the regular national surveys of smoking in secondary schoolchildren aged 11-15 conducted by the Office for National Statistics. Since 1988 these have incorporated measures of saliva cotinine concentration in a random half of the schools surveyed. Full details of the survey methodology, which remained substantially unchanged over the period we consider, are given in published reports.[6-12]

The children we included for study were self reported non-smokers (including those who never smoked, those who had tried smoking, and former smokers) who also reported not smoking in a diary covering the previous seven days. To exclude children who denied their smoking, we restricted our study to those with cotinine concentrations below 15 ng/ml, a suggested cutoff point for active smoking.[13] Parental smoking was categorised as non-smoking household (neither parent smokes or lone non-smoking parent), only father smokes, only mother smokes, both parents smoke. Parental smoking was not reported in the 1998 survey.

Cotinine concentrations--Cotinine was assayed by gas chromatography with a detection limit of 100 pg/ml.[14] To check for drift in the assay over time, in 1994 we reanalysed 25 samples gathered and analysed in 1990. The means were identical (2.4 ng/ml), and the Pearson correlation was high (r = 0.99).

Statistical analysis--Since the distribution of cotinine concentrations in non-smokers is positively skewed, we subjected the data to logarithmic transformation, first assigning a value of 0.05 to undetectable concentrations. We report geometric mean concentrations and their 95% confidence intervals. We allowed for the clustered, school based sampling frame by fitting school as a random effect in the "Mixed" procedure in SAS. All trends were tested by fitting year as a linear trend.

Results

Table 1 shows the reported prevalence of parental cigarette smoking. The percentage of children living in non-smoking households rose from 48% in 1988 to 57% in 1994 but declined in 1996 to 55%, reflecting the increased prevalence of smoking in younger adults registered in the general household survey for that year.[15]

Table 1 Prevalence of parental cigarette smoking reported by schoolchildren aged 11-15 in England

Figure 1 shows cotinine concentrations in all non-smoking children, irrespective of parental smoking habits. The geometric mean approximately halved between 1988 and 1998, from 0.96 ng/ml to 0.52 ng/ml (table 2), and the linear trend across years was highly significant (P [is less than] 0.0001).

[Figure 1 ILLUSTRATION OMITTED]

Table 2 Saliva cotinine concentrations (ng/ml) in non-smoking children aged 11-15 in England by parental smoking

NA=not available.

Cotinine concentrations in children from non-smoking homes provide the best guide to trends in passive smoking in society generally, since any exposure to smoke presumably occurs largely outside the home. Concentrations declined significantly between 1988 and 1996, from a geometric mean of 0.47 ng/ml to 0.28 ng/ml (P [is less than] 0.0001) (see table 2 and fig 2).

[Figure 2 ILLUSTRATION OMITTED]

Changes over time in cotinine concentrations in children with parents who smoked were less marked than in children from non-smoking homes (table 2 and fig 2). Concentrations in children whose father alone smoked showed a significant decline over time (P [is less than] 0.0001), whereas changes in concentrations in children whose mother alone smoked or whose mother and father both smoked were of borderline significance (P = 0.04 and P = 0.089 respectively).

Discussion

These results show a substantial decline in children's exposure to passive smoking in England since the late 1980s. On average, measured cotinine concentrations declined by almost a half between 1988 and 1998. The possibility that the findings could be an artefact explained by drift over time in the laboratory cotinine assay was ruled out by the almost identical results obtained from repeat assays of specimens from earlier years.

Changes in children's exposure to other people's tobacco smoke could be due to several factors. Among these, the most important is parental smoking. Previous work has shown that this is the main influence on children's cotinine concentrations and that exposure outside the home is quantitatively less important, especially in children aged under 16 years[16 17] Our results confirm this. Reductions in the prevalence of parental smoking have been an important factor driving the reduction in the population burden of passive smoking in children.

Children's exposure to smoke is also influenced by the extent of smoking in the community they live in--for example, smoking in friends' homes, among visitors to their own homes, and in public places. We did not have direct information about such exposures. However, the continuing reductions in cotinine concentrations in children living in non-smoking households suggest that changes in society have led to an overall less smoky environment.

We found only small declines in exposure among children with smoking parents. Some decline would be expected from the reduction in community smoking in general. We do not know to what extent smoking parents in England have adopted policies to protect their children from exposure to tobacco smoke similar to those reported in other countries,[2-5] but certainly the impact of any such measures is hard to detect at the population level. Testing the effectiveness of such policies would require more detailed and explicit quantitative evaluation.

Conclusions

Children's exposure to environmental tobacco smoke has declined substantially in England over the past decade. This has been due both to reductions in the prevalence smoking in young adults with children and to the increased restrictions on smoking in public places. There is little evidence that parents who smoke have achieved meaningful reductions in their children's exposure through limiting when and where they smoke. Complete cessation remains the only option that can be firmly endorsed, not only for parents' own health but also for their children's.

What is already known on this topic

Over the past decade smoking bans in public places have grown

It is not known whether smoking parents have avoided smoking in the home to protect their children

What this study adds

Cotinine concentrations in non-smoking children in Britain have almost halved from 1988 to 1998

This reduction is accounted for mainly by reductions in exposure in children from non-smoking homes and from a fall in the percentage of parents smoking

We thank the Imperial Cancer Research Fund for its support for the Nicotine Laboratory at the Medical Toxicology Unit, and Iain Carey for help with statistical analyses

Contributors: MJJ initiated this study, collated and analysed the data, and drafted the paper. EG and VH were responsible for designing and carrying out the survey field work. CF and AB performed the cotinine assays. DGC contributed to the data analysis and to drafting the paper. MJJ is guarantor for this study.

Funding: MJJ and AB are supported by the Imperial Cancer Research Fund.

Competing interests: None declared.

[1] Cook DG, Strachan DP. Health effects of passive smoking--10: summary of effects of parental smoking on the respiratory health of children and implications for research. Thorax 1999;54:357-66.

[2] US Centers for Disease Control and Prevention. State-specific prevalence of cigarette smoking among adults, and children's and adolescents' exposure to environmental tobacco smoke--United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:1038-43.

[3] Eriksen W, Bruusgaard D. Smoking behaviour in young families. Do parents take practical measures to prevent passive smoking by the children? Scand J Prim Health Care 1995;13:275-80.

[4] Jaakkola N, Ruotsalainen R, Jaakkola JJ. What are the determinants of children's exposure to environmental tobacco smoke at home? Scand J Soc Med 1994;22:107-12.

[5] Borland R, Mullins R, Trotter L, White V. Trends in environmental tobacco smoke restrictions in the home in Victoria, Australia. Tobacco Control 1999;8:266-71.

[6] Goddard E. Smoking among secondary schoolchildren in England in 1988. London: HMSO, 1989.

[7] Lader D, Matheson J. Smoking among secondary schoolchildren in 1990. London: HMSO, 1991.

[8] Thomas M, Holroyd S, Goddard E. Smoking among secondary schoolchildren in 1992. London: HMSO, 1993.

[9] Bolling K. Smoking among secondary schoolchildren in 1993. London: HMSO, 1994.

[10] Diamond A, Goddard E. Smoking among secondary schoolchildren in 1994. London: HMSO, 1995.

[11] Jarvis L. Smoking among secondary school children in 1996: England. London: Stationery Office, 1997.

[12] Goddard E, Higgins V. Smoking, drinking and drug use among young teenagers in 1998. Vol 1. England. London: Stationery Office, 1999.

[13] McNeill AD, Jarvis MJ, West R, Russell MAH, Bryant A. Saliva cotinine as an indicator of cigarette smoking in adolescents. Br J Addict 1987;82:1355-60.

[14] Feyerabend C, Russell MAH. A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 1990;42:450-2.

[15] Thomas M, Walker A, Wilmot A, Bennett N. Living in Britain: results from the 1996 general household survey. London: Stationery Office, 1998.

[16] Jarvis MJ, Strachan DP, Feyerabend C. Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health 1992;82:1225-9.

[17] Jarvis MJ, McNeill AD, Bryant A, Russell MA. Factors determining exposure to passive smoking in young adults living at home: quantitative analysis using saliva cotinine concentrations. Int J Epidemiol 1991;20: 26-31.

(Accepted 14 June 2000)

ICRF Health Behaviour Unit, Department of Epidemiology and Public Health, University College London, London WC1E 6BT

Martin J Jarvis professor of health psychology

Office for National Statistics, Drummond Gate, London SW1V 2QQ

Eileen Goddard principal survey researcher

Vanessa Higgins survey researcher

Medical Toxicology Unit, New Cross Hospital, London SE14 5ER

Colin Feyerabend principal biochemist

Andrew Bryant senior analyst

Department of Public Health Sciences, St George's Hospital Medical School, London SW17 0RE

Derek G Cook professor of epidemiology

Correspondence to: M J Jarvis martin.jarvis@ ucl.ac.uk

BMJ 2000;321:343-5

COPYRIGHT 2000 British Medical Association
COPYRIGHT 2000 Gale Group

Return to Cotinine
Home Contact Resources Exchange Links ebay